Found: 88
Select item for more details and to access through your institution.
Power of PgR expression as a prognostic factor for ER-positive/HER2-negative breast cancer patients at intermediate risk classified by the Ki67 labeling index.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Results from the randomized KEYNOTE-355 study of pembrolizumab plus chemotherapy for Asian patients with advanced TNBC.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00679-7
- By:
- Publication type:
- Article
Effectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 5, p. 1540, doi. 10.1007/s10637-019-00890-5
- By:
- Publication type:
- Article
TS-1 add-on therapy in Japanese patients with triple-negative breast cancer after neoadjuvant or adjuvant chemotherapy: a feasibility study.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 1, p. 140, doi. 10.1007/s10637-019-00829-w
- By:
- Publication type:
- Article
Correction to: Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Eribulin, trastuzumab, and pertuzumab as first-line therapy for patients with HER2-positive metastatic breast cancer: a phase II, multicenter, collaborative, open-label, single-arm clinical trial.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 538, doi. 10.1007/s10637-019-00755-x
- By:
- Publication type:
- Article
BRCA1 alterations with additional defects in DNA damage response genes may confer chemoresistance to BRCA-like breast cancers treated with neoadjuvant chemotherapy.
- Published in:
- Genes, Chromosomes & Cancer, 2017, v. 56, n. 5, p. 405, doi. 10.1002/gcc.22445
- By:
- Publication type:
- Article
A phase III open-label study to assess safety and efficacy of palonosetron for preventing chemotherapy-induced nausea and vomiting (CINV) in repeated cycles of emetogenic chemotherapy.
- Published in:
- Supportive Care in Cancer, 2012, v. 20, n. 7, p. 1507, doi. 10.1007/s00520-011-1239-0
- By:
- Publication type:
- Article
True Recurrences and New Primary Tumors Have Different Clinical Features in Invasive Breast Cancer Patients with Ipsilateral Breast Tumor Relapse After Breast-Conserving Treatment.
- Published in:
- Breast Journal, 2010, v. 16, n. 2, p. 127, doi. 10.1111/j.1524-4741.2009.00884.x
- By:
- Publication type:
- Article
Sentinel Lymph Node Biopsy Alone Has No Adverse Impact on the Survival of Patients with Breast Cancer.
- Published in:
- Breast Journal, 2006, v. 12, p. S157, doi. 10.1111/j.1075-122X.2006.00329.x
- By:
- Publication type:
- Article
Thalamocortical control of cell-type specificity drives circuits for processing whisker-related information in mouse barrel cortex.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41749-x
- By:
- Publication type:
- Article
Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0201846
- By:
- Publication type:
- Article
A possible aid in targeted insertion of large DNA elements by CRISPR/Cas in mouse zygotes.
- Published in:
- Genesis: The Journal of Genetics & Development, 2016, v. 54, n. 2, p. 65, doi. 10.1002/dvg.22914
- By:
- Publication type:
- Article
Prognostic utility of tumor-infiltrating lymphocytes in residual tumor after neoadjuvant chemotherapy with trastuzumab for HER2-positive breast cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38272-1
- By:
- Publication type:
- Article
Illness Perceptions and Quality of Life in Patients with Non-Small-Cell Lung Cancer: A 3-Month Follow-Up Pilot Study.
- Published in:
- Patient Related Outcome Measures, 2020, v. 11, p. 67, doi. 10.2147/PROM.S238009
- By:
- Publication type:
- Article
Morphological Study of the Accommodative Apparatus in the Monkey Eye.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2015, v. 298, n. 3, p. 630, doi. 10.1002/ar.23100
- By:
- Publication type:
- Article
Developmental Anatomy in the Zonular Connection with Lens Capsule in Macaque Eye.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2013, v. 296, n. 5, p. 726, doi. 10.1002/ar.22684
- By:
- Publication type:
- Article
Developmental Anatomy in the Zonular Connection with Lens Capsule in Macaque Eye.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2013, v. 296, n. 5, p. C1, doi. 10.1002/ar.22561
- By:
- Publication type:
- Article
Induction therapy with paclitaxel and bevacizumab followed by switch maintenance therapy with eribulin in Japanese patients with HER2-negative metastatic breast cancer: a multicenter, collaborative, open-label, phase II clinical study for the SBCCSG 35 investigators.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks)
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 207, n. 1, p. 33, doi. 10.1007/s10549-024-07333-7
- By:
- Publication type:
- Article
A randomized, 3-arm, neoadjuvant, phase 2 study comparing docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP), TCbHP followed by trastuzumab emtansine and pertuzumab (T-DM1+P), and T-DM1+P in HER2-positive primary breast cancer
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 1, p. 135, doi. 10.1007/s10549-020-05524-6
- By:
- Publication type:
- Article
β<sub>2</sub>-Adrenergic receptor expression is associated with biomarkers of tumor immunity and predicts poor prognosis in estrogen receptor-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 177, n. 3, p. 603, doi. 10.1007/s10549-019-05341-6
- By:
- Publication type:
- Article
Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 3, p. 675, doi. 10.1007/s10549-018-4873-0
- By:
- Publication type:
- Article
HER2 intratumoral heterogeneity analyses by concurrent HER2 gene and protein assessment for the prognosis of HER2 negative invasive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 1, p. 99, doi. 10.1007/s10549-016-3856-2
- By:
- Publication type:
- Article
Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 157, n. 2, p. 295, doi. 10.1007/s10549-016-3808-x
- By:
- Publication type:
- Article
Randomized phase II study of weekly paclitaxel with and without carboplatin followed by cyclophosphamide/epirubicin/5-fluorouracil as neoadjuvant chemotherapy for stage II/IIIA breast cancer without HER2 overexpression.
- Published in:
- Breast Cancer Research & Treatment, 2014, v. 145, n. 2, p. 401, doi. 10.1007/s10549-014-2947-1
- By:
- Publication type:
- Article
Prognostic significance of tumour-infiltrating lymphocytes for oestrogen receptor-negative breast cancer without lymph node metastasis.
- Published in:
- Oncology Letters, 2019, v. 17, n. 3, p. 2647
- By:
- Publication type:
- Article
Localization of Papillofoveal Bundles in Primates.
- Published in:
- Anatomical Record: Advances in Integrative Anatomy & Evolutionary Biology, 2012, v. 295, n. 2, p. 347, doi. 10.1002/ar.21519
- By:
- Publication type:
- Article
Overall survival in Japanese patients with ER+/HER2− advanced breast cancer treated with first-line palbociclib plus letrozole.
- Published in:
- Breast Cancer (13406868), 2024, v. 31, n. 1, p. 53, doi. 10.1007/s12282-023-01511-z
- By:
- Publication type:
- Article
Efficacy and safety of talazoparib in Japanese patients with germline BRCA-mutated locally advanced or metastatic breast cancer: results of the phase 1 dose-expansion study.
- Published in:
- Breast Cancer (13406868), 2022, v. 29, n. 6, p. 1088, doi. 10.1007/s12282-022-01390-w
- By:
- Publication type:
- Article
Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 5, p. 1038, doi. 10.1007/s12282-021-01239-8
- By:
- Publication type:
- Article
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in Japan.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 4, p. 945, doi. 10.1007/s12282-021-01232-1
- By:
- Publication type:
- Article
Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3.
- Published in:
- Breast Cancer (13406868), 2021, v. 28, n. 2, p. 335, doi. 10.1007/s12282-020-01162-4
- By:
- Publication type:
- Article
Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
- Published in:
- Breast Cancer (13406868), 2019, v. 26, n. 5, p. 637, doi. 10.1007/s12282-019-00970-7
- By:
- Publication type:
- Article
Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Impact of immediate breast reconstruction on postoperative adjuvant chemotherapy: a single center study.
- Published in:
- Breast Cancer (13406868), 2015, v. 22, n. 3, p. 287, doi. 10.1007/s12282-013-0480-4
- By:
- Publication type:
- Article
A multicenter phase II study of TSU-68, an oral multiple tyrosine kinase inhibitor, in combination with docetaxel in metastatic breast cancer patients with anthracycline resistance.
- Published in:
- Breast Cancer (13406868), 2014, v. 21, n. 1, p. 20, doi. 10.1007/s12282-012-0344-3
- By:
- Publication type:
- Article
Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients.
- Published in:
- Breast Cancer (13406868), 2011, v. 18, n. 3, p. 195, doi. 10.1007/s12282-011-0259-4
- By:
- Publication type:
- Article
Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages?
- Published in:
- Breast Cancer (13406868), 2011, v. 18, n. 2, p. 85, doi. 10.1007/s12282-010-0239-0
- By:
- Publication type:
- Article
Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
- Published in:
- Breast Cancer (13406868), 2010, v. 17, n. 1, p. 9, doi. 10.1007/s12282-009-0154-4
- By:
- Publication type:
- Article
Deletion of Class II ADP-Ribosylation Factors in Mice Causes Tremor by the Nav1.6 Loss in Cerebellar Purkinje Cell Axon Initial Segments.
- Published in:
- Journal of Neuroscience, 2019, v. 39, n. 32, p. 6339, doi. 10.1523/jneurosci.2002-18.2019
- By:
- Publication type:
- Article
Palbociclib in combination with fulvestrant in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-3 subgroup analysis of Japanese patients.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 3, p. 262, doi. 10.1007/s10147-018-1359-3
- By:
- Publication type:
- Article
Safety, pharmacokinetics and efficacy findings in an open-label, single-arm study of weekly paclitaxel plus lapatinib as first-line therapy for Japanese women with HER2-positive metastatic breast cancer.
- Published in:
- International Journal of Clinical Oncology, 2015, v. 20, n. 6, p. 1102, doi. 10.1007/s10147-015-0832-5
- By:
- Publication type:
- Article
Tamoxifen versus tamoxifen plus doxorubicin and cyclophosphamide as adjuvant therapy for node-positive postmenopausal breast cancer: results of a Japan Clinical Oncology Group Study (JCOG9401).
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 6, p. 982, doi. 10.1007/s10147-013-0657-z
- By:
- Publication type:
- Article
A multicenter phase II study of TSU-68, a novel oral multiple tyrosine kinase inhibitor, in patients with metastatic breast cancer progressing despite prior treatment with an anthracycline-containing regimen and taxane.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 4, p. 590, doi. 10.1007/s10147-012-0421-9
- By:
- Publication type:
- Article
Sentinel lymph node biopsy after neoadjuvant chemotherapy predicts pathological axillary lymph node status in breast cancer patients with clinically positive axillary lymph nodes at presentation.
- Published in:
- International Journal of Clinical Oncology, 2013, v. 18, n. 3, p. 547, doi. 10.1007/s10147-012-0418-4
- By:
- Publication type:
- Article
Palbociclib‐letrozole as first‐line treatment for advanced breast cancer: Updated results from a Japanese phase 2 study.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 14, p. 4929, doi. 10.1002/cam4.3091
- By:
- Publication type:
- Article
Clinicopathological values of PD-L1 expression in HER2-positive breast cancer.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-52944-6
- By:
- Publication type:
- Article
A phase 3 safety study of fosnetupitant as an antiemetic in patients receiving anthracycline and cyclophosphamide: CONSOLE‐BC.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 8, p. 1692, doi. 10.1002/cncr.34088
- By:
- Publication type:
- Article
Quality of life and its associations with illness perceptions over a 3-month follow-up period in patients with non-small cell lung cancer: A prospective longitudinal study.
- Published in:
- World Academy of Sciences Journal, 2021, p. 1, doi. 10.3892/wasj.2021.126
- By:
- Publication type:
- Article